IDiyas

For the Inventor, By the Inventor

Nyon, Switzerland

Eric Joseph Niesor

USPTO Granted Patents = 19 

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 107(Granted Patents)


Location History:

  • Gland, CH (1982 - 1987)
  • Geneva, CH (2000 - 2003)
  • Nyon, CH (1991 - 2023)

Company Filing History:

goldMedal9 out of 12 
 
Symphar S.a.
 patents
silverMedal5 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents
bronzeMedal3 out of 6 
 
Ilex Products, Inc.
 patents
4. 1 out of 2,198 
 
Smithkline Beecham Corporation
 patents
5. 1 out of 1 
 
Ilex Oncology Research S.a.
 patent
6. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1982-2023

Loading Chart...
19 patents (USPTO):Explore Patents
1. 11549142 - CETP inhibitors for therapeutic use (2023-01-10),
2. 10711303 - CETP inhibitors for therapeutic use (2020-07-14),
3. 9909178 - Dalcetrapib for therapeutic use (2018-03-06),
4. 8178583 - Compounds (2012-05-15),
5. 7645785 - Benzimidazole derivatives (2010-01-12),
6. 7208481 - Aminodiphosphonate apolipoprotein E modulators (2007-04-24),
7. 6872711 - β-substituted β-aminoethyl phosphonate derivatives (2005-03-29),
8. 6706698 - &agr;-Substituted &bgr;-aminoethyl phosphonate derivatives (2004-03-16),
9. 6660724 - Compounds and pharmaceutical compositions containing them (2003-12-09),
10. 6303784 - Pharmaceutical aminophosphonic acid derivatives (2001-10-16),
11. 6127350 - Use of phenol substituted diphosphonates as antineoplastic agents (2000-10-03),
12. 6060464 - Compounds and pharmaceutical compositions containing them (2000-05-09),
13. 5424303 - Substituted aminophosphonate derivatives, process for their preparation (1995-06-13),
14. 5128331 - Method for lowering plasma lipid levels or blood pressure (1992-07-07),
15. 5043330 - Phenol substituted gem-diphosphonate derivatives, process for their (1991-08-27),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about inventor Eric Joseph Niesor.

Title: Exploring the Inventive Journey of Eric Joseph Niesor

Introduction: Eric Joseph Niesor, a distinguished inventor hailing from Nyon, Switzerland, has made significant contributions to the field of cardiovascular disease treatment through his innovative patents and relentless research efforts.

Latest Patents: With an impressive portfolio of 19 patents, one of his notable inventions includes "CETP Inhibitors for Therapeutic Use." This pioneering invention revolutionizes genotyping methods and compositions for selecting cardiovascular disease patients who would benefit from treatment with HDL-raising agents, particularly CETP inhibitors/modulators.

Career Highlights: Eric Joseph Niesor has honed his craft at renowned companies such as Symphar S.A. and Hoffmann-La Roche Inc., where his expertise and dedication have played a vital role in shaping the landscape of cardiovascular therapeutics.

Collaborations: Throughout his illustrious career, Eric Joseph Niesor has collaborated with esteemed professionals in the industry, including Craig Leigh Bentzen and Hieu Trung Phan. These collaborations have led to groundbreaking advancements in the field of cardiovascular medicine.

Conclusion: Eric Joseph Niesor's unwavering commitment to innovation and his groundbreaking contributions to cardiovascular disease treatment exemplify his prowess as an inventor. His patents continue to pave the way for novel therapeutic interventions, marking him as a visionary in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…